Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Breast Cancer Female × darolutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 47 Prostatic Neoplasms, Castration-Resistant 5 Neoplasm Metastasis 4 Salivary Gland Neoplasms 3 Prostatic Diseases 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Male Urogenital Diseases 2 Genital Diseases, Male 2 Bulbo-Spinal Atrophy, X-Linked 2 Breast Neoplasms 2 Biochemically Recurrent Prostate Cancer 2 Adenocarcinoma 2 Urogenital Neoplasms 1 Urogenital Diseases 1 Triple Negative Breast Neoplasms 1 Thrombocytosis 1 Prostate Cancer Non-Metastatic 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Lymphoma, Non-Hodgkin 1

Interventions

Tamoxifen 3 Exercise 3 pyrotinib 2 abemaciclib 2 Paclitaxel 2 Metformin 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 palbociclib 1 iniparib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03383679 2022-11-21

START

UNICANCER

Phase 2 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡